Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EIGR
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

FAQ

What is the symbol for Eiger BioPharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Eiger BioPharmaceuticals, Inc. is EIGR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Eiger BioPharmaceuticals, Inc. Stock?
Eiger BioPharmaceuticals, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Eiger BioPharmaceuticals, Inc. Stock?
Eiger BioPharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Eiger BioPharmaceuticals, Inc. Stock.

What's the current price of Eiger BioPharmaceuticals, Inc. Stock?
As of the end of day on the Jul 03, 2024, the price of an Eiger BioPharmaceuticals, Inc. (EIGR) share was $1.73.

What is the 52-week high and low for Eiger BioPharmaceuticals, Inc. Stock?
The 52-week high for Eiger BioPharmaceuticals, Inc. Stock is $8.27 and the 52-week low is $0.200.

What is the market capitalization of Eiger BioPharmaceuticals, Inc. Stock?
As of the Jul 03, 2024, the market capitalization of Eiger BioPharmaceuticals, Inc. is 2.552M.

When is the next earnings date for Eiger BioPharmaceuticals, Inc.?
The upcoming earnings date for Eiger BioPharmaceuticals, Inc. is Aug 12, 2024.
Click to get the best stock tips daily for free!

About Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals. Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infection. The company's product candidate also include Lambda, which targe... EIGR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT